Empresa Cantabio Pharmaceuticals Inc. Other OTC
Acciones
CTBO
US13808X2036
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Johnny He
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 22 549 | 6 763 ( 29,99 %) | 0 | 29,99 % |
Información de la empresa
Cantabio Pharmaceuticals, Inc.
2225 East Bayshore Road Suite 200
94303, Palo Alto
+
http://www.cantabio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+54,05 % | 63,85 mil M | |
-2,02 % | 41,83 mil M | |
+40,01 % | 40,47 mil M | |
-10,22 % | 27,17 mil M | |
+13,42 % | 26,52 mil M | |
-21,60 % | 18,69 mil M | |
+2,89 % | 12,73 mil M | |
+22,40 % | 12,11 mil M | |
+27,49 % | 12,07 mil M |